Novo Nordisk and Eli Lilly Develop Pill Versions of Weight-Loss Drugs, Posing Cost and Side-Effect Concerns
Major pharmaceutical companies Novo Nordisk A/S and Eli Lilly & Co. are highlighting upcoming pill versions of their successful weight-loss drugs, expected to hit the market as early as next year. However, hopes for more affordable options with fewer side effects may be dashed, raising concerns for both patients and insurers. The blockbuster injections, such … Read more